CASI Pharmaceuticals (CASI) Competitor Comparison
We are evaluating the key criteria listed to compare CASI Pharmaceuticals (CASI) against its competitors in the Biotechnology industry.
Market Capitalization
279 / 368Gross Profits
0 / 278Total Revenue
132 / 300EBITDA
99 / 337Free Cashflow
0 / 352Quick Ratio
217 / 357Earnings per Share
208 / 359Dividend yield
0 / 6Total Cash
279 / 358Performance 3 years
142 / 368Performance 5 years
242 / 368Performance 10 years
171 / 368Linearity 3 years
95 / 368Linearity 5 years
246 / 368Linearity 10 years
64 / 368Total Rank
20 / 368Dividend Rank
33 / 368Valuation Rank
123 / 368Piotroski Rank
58 / 368Muliplier Rank
44 / 368Total Revenue - CASI ranking 132 / 300
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.